Cms Issues First Request For Public Comments On The Medicare Drug Price Negotiation Program Quot Small Biotech Exception X2013 Due March 27 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
The Inflation Reduction Act's ("IRA") drug price negotiation provisions have captured the pharmaceutical and biotech industry's attention. In part, the IRA allows the Centers for Medicare & Medicaid